Rialto Wealth Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Rialto Wealth Management's PCVX Position: Q3 2026 in Review
Rialto Wealth Management increased its Vaxcyte (PCVX) stake by 100% in Q3 2026, buying an estimated $641 and bringing the position to 22 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.
Rialto Wealth Management first reported a position in PCVX in Q2 2025 and has held it in 3 quarters since. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Rialto Wealth Management held 22 shares of Vaxcyte worth $1.25K as of Q3 2026.
- Rialto Wealth Management bought 11 Vaxcyte shares in Q3 2026, an estimated $641.
- Vaxcyte made up ﹤0.01% of Rialto Wealth Management's portfolio in Q3 2026, its #1299 holding.
- Rialto Wealth Management first reported a position in Vaxcyte in Q2 2025 and has held it in 3 quarters since.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.